RESUMEN
Many factors influence neurodevelopment. However, their contribution to adult neural function is often unclear. This is often due to complex expression profiles, cell signalling, neuroanatomy, and a lack of effective tests to assess the function of neural circuits in vivo. Ephrin-A2 and ephrin-A5 are cell surface proteins implicated in multiple aspects of neurodevelopment. While the role of ephrin-As in visual, auditory and learning behaviours has been explored, little is known about their role in dopaminergic and neuromotor pathways, despite expression in associated brain regions. Here we probe the function of ephrin-A2 and ephrin-A5 in the development of the dopaminergic and neuromotor pathways using counts of tyrosine hydroxylase (TH) positive cells in the substantia nigra pars compacta (SNpc) and the ventral tegmental area (VTA), the acoustic startle reflex (ASR), and a measure of sensorimotor gating, prepulse inhibition (PPI). Analysis of the ASR and PPI in ephrin-A2 and/or ephrin-A5 knock-out mice revealed that both genes play distinct roles in mediating ASR circuits, but are unlikely to play a role in PPI. Knock-out of either gene resulted in robust changes in startle response magnitude and measures of startle onset and peak latencies. However, ephrin-A2 and ephrin-A5 regulate aspects of the ASR differently: ephrin-A2 KO mice have increased startle amplitude, increased sensitivity and reduced latency to startle, whilst ephrin-A5 KO mice show opposite effects. Neither of the gene knock outs affected PPI, despite ephrin-A5 KO mice showing changes in dopamine cell numbers in nuclei thought to regulate PPI. We propose that majority of the changes observed ephrin-A2 and ephrin-A5 KO mice appear to be mediated by the effects on motor neurons and their muscle targets, rather than changes in auditory sensitivity.
Asunto(s)
Efrina-A2/deficiencia , Efrina-A5/deficiencia , Inhibición Neural/genética , Filtrado Sensorial/genética , Estimulación Acústica , Análisis de Varianza , Animales , Efrina-A2/genética , Efrina-A5/genética , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Porción Compacta de la Sustancia Negra/metabolismo , Tiempo de Reacción/genética , Reflejo de Sobresalto/genética , Tirosina 3-Monooxigenasa/metabolismo , Área Tegmental Ventral/metabolismoRESUMEN
RATIONALE: Amphetamine challenge in rodent prepulse inhibition (PPI) studies has been used to model potential dopamine involvement in effects that may be relevant to schizophrenia, though similar studies in healthy humans have failed to report replicable or robust effects. OBJECTIVES: The present study investigated dexamphetamine effects on PPI in healthy humans with an increased dose and a range of startling stimulus intensities to determine participants' sensitivity and range of responses to the stimuli. METHODS: A randomised, placebo-controlled dexamphetamine (0.45 mg/kg, per os.), double-blind, counterbalanced, within-subject design was used. PPI was measured in 64 participants across a range of startling stimulus intensities, during two attention set conditions (ATTEND and IGNORE). Startle magnitudes for pulse-alone and prepulse-pulse magnitudes were modelled using the startle reflex magnitude (sigmoid) function. Parameters were extracted from these fits, including the upper limit of the asymptote (maximum startle reflex capacity, R MAX), intensity threshold, stimulus intensity that elicits a half-maximal response (ES50) and the maximum rate of change of startle response magnitude to an increase in stimulus intensity. RESULTS: Dexamphetamine increased the threshold and ES50 of the response to pulse-alone trials in both sexes and reduced R MAX exclusively in females. Dexamphetamine modestly increased PPI of the R MAX across both attention conditions. PPI of R MAX was reduced during the ATTEND condition compared to the IGNORE condition. CONCLUSIONS: Results indicate that sex differences exist in motor, but not sensory, components of the startle reflex. Findings also reveal that administration of 0.45 mg/kg dexamphetamine to healthy humans does not mimic PPI effects observed in schizophrenia.
Asunto(s)
Estimulantes del Sistema Nervioso Central/farmacología , Dextroanfetamina/farmacología , Inhibición Prepulso/efectos de los fármacos , Reflejo de Sobresalto/efectos de los fármacos , Caracteres Sexuales , Estimulación Acústica , Atención/efectos de los fármacos , Atención/fisiología , Método Doble Ciego , Femenino , Humanos , Masculino , Pruebas Neuropsicológicas , Inhibición Prepulso/fisiología , Desempeño Psicomotor/efectos de los fármacos , Desempeño Psicomotor/fisiología , Psicofarmacología , Reflejo de Sobresalto/fisiología , Adulto JovenRESUMEN
BACKGROUND: An emerging endophenotype of schizophrenia is the reduction of both power and phase locking of the 40 Hz auditory steady state response (ASSR), and there have been a number of reports linking increased γ activity with positive psychotic symptoms. Schizophrenia and, more specifically, positive psychotic symptoms have been closely linked to increased dopamine (DA) neurophysiology. Therefore, we gave dexamphetamine to healthy participants to determine the effect that increased DA transmission would have on the ASSR. METHODS: We administered 0.45 mg/kg of dexamphetamine orally in a double-blind placebo-controlled crossover study. Stimuli were 20 Hz and 40 Hz click trains presented in an auditory oddball-type stimulus format (probability of stimulus presentation: 0.2 for targets, 0.8 for nontargets). RESULTS: We included 44 healthy volunteers (18 women) in the study. Dexamphetamine significantly increased the 40 Hz power for both target and nontarget ASSR stimuli. Dexamphetamine did not significantly affect the 40 Hz phase-locking factor (PLF) or the 20 Hz power and PLF. Whereas there were significant effects of selective attention on power and PLF for 20 and 40 Hz ASSR, there were no significant interactions between dexamphetamine and selective attention. LIMITATIONS: Dexamphetamine releases both noradrenaline and DA with equal potency. Further research with selective dopaminergic and noradrenergic agents will better characterize the effects of monoamines on γ activity. CONCLUSION: The results demonstrate a frequency-specific effect of dexamphetamine on the ASSR. This finding is consistent with previous research that has found an association between increased γ and positive symptoms of psychosis. However, this result also raises the possibility that previous 40 Hz ASSR findings in people with schizophrenia may be confounded by effects of antipsychotic medication. Possible neural mechanisms by which dexamphetamine specifically increases 40 Hz power are also discussed. AUSTRALIAN AND NEW ZEALAND CLINICAL TRIALS REGISTRY NUMBER: ACTRN12608000610336.
Asunto(s)
Estimulantes del Sistema Nervioso Central/farmacología , Dextroanfetamina/farmacología , Potenciales Evocados Auditivos/efectos de los fármacos , Estimulación Acústica/métodos , Adulto , Corteza Auditiva/efectos de los fármacos , Estudios Cruzados , Método Doble Ciego , Electroencefalografía , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
OBJECTIVE: Schizophrenia patients and healthy cannabis users show different attention-dependant alterations in prepulse inhibition (PPI). It is of interest then to examine PPI in patients with schizophrenia who use cannabis, given the hypothesized association between cannabis use and schizophrenia. METHODS: Prepulse inhibition was measured in 34 healthy cannabis users, 32 healthy non-using controls, 20 patients with schizophrenia who were current cannabis users, and 44 non-using patients with schizophrenia. PPI was measured across a range of startling stimulus intensities, during two attention set conditions. Curves of best fit were fitted to the startle magnitudes, across the stimulus intensities. A number of reflex parameters were extracted from these logistic functions. RESULTS: Similar to healthy cannabis users, cannabis-using patients showed altered PPI of Threshold, only when instructed to sustain attention to the auditory stimuli. Conversely, non-using patients with schizophrenia showed reduced PP of R(MAX) only when instructed to ignore the auditory stimuli. CONCLUSION: Cannabis use in patients with schizophrenia is associated with a similar pattern of attention-dependant alterations in PPI to that observed in healthy cannabis users. This is different to those observed in patients with schizophrenia who do not use cannabis and may be as a result of a dysfunction of sustained attention.
Asunto(s)
Fumar Marihuana/psicología , Esquizofrenia/fisiopatología , Filtrado Sensorial/fisiología , Estimulación Acústica , Adulto , Atención/efectos de los fármacos , Atención/fisiología , Estudios de Casos y Controles , Femenino , Humanos , Masculino , Persona de Mediana Edad , Reflejo de Sobresalto/efectos de los fármacos , Reflejo de Sobresalto/fisiología , Filtrado Sensorial/efectos de los fármacos , Adulto JovenRESUMEN
Controversy exists as to the cause of disturbed prepulse inhibition (PPI) in patients with schizophrenia. This study aimed to clarify the nature of PPI in schizophrenia using improved methodology. Startle and PPI were measured in 44 patients with schizophrenia and 32 controls across a range of startling stimulus intensities under two conditions, one while participants were attending to the auditory stimuli (ATTEND condition) and one while participants completed a visual task in order to ensure they were ignoring the auditory stimuli (IGNORE condition). Patients showed reduced PPI of R(MAX) (reflex capacity) and increased PPI of Hillslope (reflex efficacy) only under the INGORE condition, and failed to show the same pattern of attentional modulation of the reflex parameters as controls. In conclusion, disturbed PPI in schizophrenia appears to result from deficits in selective attention, rather than from preattentive dysfunction.
Asunto(s)
Atención/fisiología , Reflejo de Sobresalto/fisiología , Psicología del Esquizofrénico , Estimulación Acústica , Adulto , Algoritmos , Parpadeo , Interpretación Estadística de Datos , Electroencefalografía , Femenino , Humanos , Modelos Logísticos , Masculino , Escalas de Valoración Psiquiátrica , Trastornos Psicóticos/psicología , Trastornos Relacionados con Sustancias/psicologíaRESUMEN
Regardless of a wide research interest the nature of a relationship between cannabis use and schizophrenia is controversial. One of the physiological abnormalities in schizophrenia is attention-modulated deficit in prepulse inhibition (PPI), which is a normal reduction in the startle reflex magnitude when a non-startling stimulus (prepulse) precedes the startling stimulus (pulse). This experiment was designed to determine whether or not otherwise healthy people using cannabis would exhibit attention-modulated deficit in PPI. The startle reflex was recorded in carefully screened healthy humans attending to and ignoring auditory pulse and prepulse stimuli separated by short (20-200 ms) and long prepulse intervals (1600 ms). In contrast to 12 non-using controls, cannabis use in 16 healthy humans was associated with significant reduction in%PPI while attending to auditory stimuli, but not while ignoring them. The PPI was correlated with the duration of cannabis use but not with the concentration of cannabinoid metabolites in urine and the recency of cannabis use in the preceding 24 hours. Cannabis use was not associated with changes in prepulse facilitation of startle reflex magnitude (%PPF) at long prepulse intervals, prepulse facilitation of startle reflex latency and startle reflex magnitude in the absence of prepulses. These results suggest that chronic, but not acute, use of cannabis is associated with schizophrenia-like disruption in PPI in healthy controls. Such reduction in PPI is attention-dependent and does not reflect a global deficit in sensorimotor gating in cannabis users.
Asunto(s)
Atención/efectos de los fármacos , Fumar Marihuana/psicología , Reflejo de Sobresalto/efectos de los fármacos , Estimulación Acústica , Adolescente , Adulto , Enfermedad Crónica , Femenino , Humanos , Masculino , Desempeño Psicomotor/efectos de los fármacosRESUMEN
RATIONALE: Emotional modulation of the startle reflex in the rat may be used to assess whether activation of dopamine receptors specifically increases hedonia, incentive, fear or arousal. OBJECTIVES: The objective of the study is to determine the effects of apomorphine (0.8 mg/kg s.c.) on the startle reflex of rats (72 male Sprague-Dawley rats) exposed to one of three affective conditions. These conditions were negative affective stimulus (exposure to cat smell), positive affective stimulus (availability of a 20% sucrose solution), neutral stimulus (no additional affective stimulus) and one of two appetitive "drive" states (food deprived or non-food deprived). METHODS: The startle response (whole-body flinch response) was measured after presentation of a range of intensities of acoustic stimuli (65-120 dB, 40-ms duration white noise). The resulting sigmoidal stimulus intensity-response magnitude (SIRM) curves were fitted using a logistic regression procedure, and features of these functions were abstracted for analysis. RESULTS: Maximal startle amplitudes were increased by the negative affect (fear) stimulus in non-food-deprived rats and decreased by the positive affect stimulus in food-deprived rats. Apomorphine mimicked the effects of food deprivation under both affect conditions, but also produced an effect in food-deprived rats similar to that of the positive affect condition. CONCLUSIONS: The results are consistent with both a positive incentive effect and a direct hedonic action of apomorphine, but inconsistent with a role in general arousal. In addition, a method of analysing SIRM functions with logistic regressions is introduced as a useful means of standardising startle reflex measurements.
Asunto(s)
Apomorfina/farmacología , Reflejo de Sobresalto/efectos de los fármacos , Estimulación Acústica/métodos , Análisis de Varianza , Animales , Peso Corporal/efectos de los fármacos , Peso Corporal/fisiología , Agonistas de Dopamina/farmacología , Emoción Expresada/efectos de los fármacos , Emoción Expresada/fisiología , Privación de Alimentos/fisiología , Percepción Sonora/efectos de los fármacos , Percepción Sonora/fisiología , Masculino , Ratas , Ratas Sprague-Dawley , Reflejo de Sobresalto/fisiología , Sacarosa/administración & dosificación , Sacarosa/farmacologíaRESUMEN
Rat strain differences in the acoustic startle response (ASR) and prepulse inhibition (PPI) of that response are of increasing interest, especially as the genetics of PPI may provide an approach to studying the genetics of certain mental illnesses. However, strain differences in PPI are confounded by differences in ASR. To clarify this issue, the authors investigated the ASR and PPI across a range of startling stimulus intensities (70 dB-120 dB) in Wistar and Sprague-Dawley rats (N=96). Sprague-Dawleys showed more PPI of ASR capacity (response limit) than Wistars. In contrast, Wistars exhibited greater PPI than Sprague-Dawleys, as measured by an increase in response threshold. This dissociation suggests that PPI is more complex than that assessed by single startling stimulus intensity.